- Home
- ACNB vs VNDA Comparison
ACNB vs VNDA Comparison
Compare ACNB & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- VNDA
- Stock Information
- Founded
- ACNB 1857
- VNDA 2002
- Country
- ACNB United States
- VNDA United States
- Employees
- ACNB N/A
- VNDA N/A
- Industry
- ACNB Major Banks
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- ACNB Finance
- VNDA Health Care
- Exchange
- ACNB Nasdaq
- VNDA Nasdaq
- Market Cap
- ACNB 450.1M
- VNDA 261.7M
- IPO Year
- ACNB N/A
- VNDA 2006
- Fundamental
- Price
- ACNB $42.84
- VNDA $4.78
- Analyst Decision
- ACNB Strong Buy
- VNDA Strong Buy
- Analyst Count
- ACNB 4
- VNDA 3
- Target Price
- ACNB $50.00
- VNDA $15.33
- AVG Volume (30 Days)
- ACNB 35.6K
- VNDA 408.4K
- Earning Date
- ACNB 07-23-2025
- VNDA 07-30-2025
- Dividend Yield
- ACNB 3.08%
- VNDA N/A
- EPS Growth
- ACNB N/A
- VNDA N/A
- EPS
- ACNB 2.79
- VNDA N/A
- Revenue
- ACNB $113,448,000.00
- VNDA $201,351,000.00
- Revenue This Year
- ACNB $38.67
- VNDA $16.86
- Revenue Next Year
- ACNB $5.26
- VNDA $39.78
- P/E Ratio
- ACNB $15.82
- VNDA N/A
- Revenue Growth
- ACNB 8.66
- VNDA 13.37
- 52 Week Low
- ACNB $35.28
- VNDA $3.81
- 52 Week High
- ACNB $50.72
- VNDA $6.37
- Technical
- Relative Strength Index (RSI)
- ACNB 50.00
- VNDA 53.88
- Support Level
- ACNB $43.87
- VNDA $4.85
- Resistance Level
- ACNB $45.10
- VNDA $5.12
- Average True Range (ATR)
- ACNB 1.00
- VNDA 0.18
- MACD
- ACNB 0.08
- VNDA 0.01
- Stochastic Oscillator
- ACNB 48.52
- VNDA 54.05
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.